Roche gets CE mark for blood test detecting Alzheimer's gene variant

March 16, 2026 2:00 AM

Roche (SIX: RO, ROG; OTCQX: RHHBY) received CE mark approval for its Elecsys ApoE4 test, the first in-vitro diagnostic immunoassay ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found